1-1 of 1
Esteban M. Abella, MD
Close
Sort by
Journal Articles

Exposure-Response of Entospletinib (ENTO) for the Treatment of Relapsed or Refractory Chronic Lymphocytic Leukemia

Sneha Gupta, PhD, Amy Meng, PhD, Shringi Sharma, PhD, Wei Ye, PhD, Jeffrey Silverman, PhD, Esteban M. Abella, MD, Anita Mathias, PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1735.
https://doi.org/10.1182/blood.V130.Suppl_1.1735.1735
Published: 2017